The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of the timing of hepatitis B virus (HBV) identification and anti-HBV therapy initiation on the risk of adverse liver outcomes in patients receiving cancer therapy.
 
Jessica Hwang
No Relationships to Disclose
 
Maria E. Suarez-Almazor
No Relationships to Disclose
 
Scott B. Cantor
No Relationships to Disclose
 
Andrea G. Barbo
No Relationships to Disclose
 
Heather Y. Lin
No Relationships to Disclose
 
Sairah Ahmed
Honoraria - Seagen
 
Mariana Chavez-Mac Gregor
Consulting or Advisory Role - InVitae; Novartis; Pfizer
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Christian Donato-Santana
No Relationships to Disclose
 
Cathy Eng
Honoraria - Bayer; Lilly; Roche
Consulting or Advisory Role - Advaxis; Bayer Schering Pharma; Forty Seven; Roche/Genentech; Sirtex Medical
Research Funding - Advaxis; Keryx
Travel, Accommodations, Expenses - Bayer; Genentech/Roche
 
Alessandra Ferrajoli
No Relationships to Disclose
 
Michael Fisch
Employment - AIM Specialty Health
Stock and Other Ownership Interests - Anthem
Consulting or Advisory Role - WellPoint
 
Peter McLaughlin
Consulting or Advisory Role - Celgene; Gilead Sciences
Travel, Accommodations, Expenses - Celgene; Gilead Sciences
 
George R. Simon
No Relationships to Disclose
 
Gabriela Rondon
No Relationships to Disclose
 
Elizabeth J. Shpall
No Relationships to Disclose
 
Anna S. F. Lok
Leadership - American Association for the Study of Liver Diseases
Research Funding - Bristol-Myers Squibb; Gilead Sciences
Patents, Royalties, Other Intellectual Property - UpToDate
Travel, Accommodations, Expenses - Gilead Sciences